Company: THC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0000070318-25-000039
Chunk: 105

Company: TENET HEALTHCARE CORP
Filing Date: 2025-07-30
Form: 10-Q
Item: Part I, Item 8
Chunk 105
---
Deferred income tax expense (benefit)11 (93)Stock-based compensation expense41 36 Impairment and restructuring charges, and acquisition-related costs43 56 Litigation and investigation costs45 9 Net losses (gains) on sales, consolidation and deconsolidation of facilities16 (2,558)Loss from early extinguishment of debt— 8 Equity in earnings of unconsolidated affiliates, net of distributions received(8)(3)Amortization of debt discount and debt issuance costs12 14 Net gains from the sale of investments and long-lived assets— (1)Other items, net(1)(3)Changes in cash from operating assets and liabilities:  Accounts receivable40 77 Inventories and other current assets9 16 Income taxes10 713 Accounts payable, accrued expenses and other current liabilities24 (124)Other long-term liabilities32 23 Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements(81)(64)Net cash provided by operating activities1,751 1,333 Cash flows from investing activities:  Purchases of property and equipment(366)(385)Purchases of businesses or joint venture interests, net of cash acquired(147)(510)Proceeds from sales of facilities and other assets14 4,048 Proceeds from sales of marketable securities and long-term investments37 17 Purchases of marketable securities and long-term investments(38)(26)Other items, net(1)(10)Net cash provided by (used in) investing activities(501)3,134 Cash flows from financing activities:  Repayments of borrowings(62)(2,179)Proceeds from borrowings15 8 Repurchases of common stock(1,095)(548)Distributions paid to noncontrolling interests(374)(323)Proceeds from the sale of noncontrolling interests18 10 Purchases of noncontrolling interests(79)(88)Advances from managed care payers— 342 Repayments of advances from managed care payers(12)— Other items, net(55)(37)Net cash used in financing activities(1,644)(2,815)Net increase (decrease) in cash and cash equivalents(394)1,652 Cash and cash equivalents at beginning of period3,019 1,228 Cash and cash equivalents at end of period$2,625